1-2 of 2
Adam Shlien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma

Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N. Hayes, Meredith S. Irwin
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (12): 2608–2622.
https://doi.org/10.1158/2767-9764.CRC-23-0234
Published: 27 December 2023
View article titled, SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
Open the PDF for SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome

Vallijah Subasri, Nicholas Light, Nisha Kanwar, Jack Brzezinski, Ping Luo, Jordan R. Hansford, Elizabeth Cairney, Carol Portwine, Christine Elser, Jonathan L. Finlay, Kim E. Nichols, Noa Alon, Ledia Brunga, Jo Anson, Wendy Kohlmann, Kelvin C. de Andrade, Payal P. Khincha, Sharon A. Savage, Joshua D. Schiffman, Rosanna Weksberg, Trevor J. Pugh, Anita Villani, Adam Shlien, Anna Goldenberg, David Malkin
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (5): 738–754.
https://doi.org/10.1158/2767-9764.CRC-22-0402
Published: 01 May 2023
View article titled, Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Open the PDF for Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome in another window
Includes: Supplementary data